author-photo

Tobias Dechow

Technische Universität München

85

Papers

2244

Citations

Citation Trend

Filter By

Papers (85) Sort By

JournalConferenceOthers

First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience.

2021 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after failure on first-line immune checkpoint inhibitor combination therapy: Initial efficacy and safety results from VARGADO Cohort C.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.

2021 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer: Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1330P Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
KRAS G12C-mutated advanced non-small cell lung cancer: a real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' method.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号